Literature DB >> 20625883

Oseltamivir dose adjustment in an H1N1 patient requiring haemodialysis.

Thibault Dolley-Hitze, Marie-Clémence Verdier, Olivier Tribut, Yves Le Tulzo, Sophie Marqué.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20625883     DOI： 10.1007/s00134-010-1943-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  The pharmacokinetics and tolerability of oseltamivir suspension in patients on haemodialysis and continuous ambulatory peritoneal dialysis.

Authors:  Richard Robson; Adrian Buttimore; Kelvin Lynn; Mike Brewster; Penelope Ward
Journal:  Nephrol Dial Transplant       Date:  2006-06-24       Impact factor: 5.992

2.  Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.

Authors:  L V Gubareva; R G Webster; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

3.  Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of oseltamivir and its metabolite oseltamivir carboxylate in plasma, saliva and urine.

Authors:  N Lindegårdh; W Hanpithakpong; Y Wattanagoon; P Singhasivanon; N J White; N P J Day
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-09-19       Impact factor: 3.205

4.  Pharmacokinetics of high-dose oseltamivir in healthy volunteers.

Authors:  Y Wattanagoon; K Stepniewska; N Lindegårdh; S Pukrittayakamee; U Silachamroon; W Piyaphanee; T Singtoroj; W Hanpithakpong; G Davies; J Tarning; W Pongtavornpinyo; C Fukuda; P Singhasivanon; N P J Day; N J White
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

5.  Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain.

Authors:  Jordi Rello; Alejandro Rodríguez; Pedro Ibañez; Lorenzo Socias; Javier Cebrian; Asunción Marques; José Guerrero; Sergio Ruiz-Santana; Enrique Marquez; Frutos Del Nogal-Saez; Francisco Alvarez-Lerma; Sergio Martínez; Miquel Ferrer; Manuel Avellanas; Rosa Granada; Enrique Maraví-Poma; Patricia Albert; Rafael Sierra; Loreto Vidaur; Patricia Ortiz; Isidro Prieto del Portillo; Beatriz Galván; Cristóbal León-Gil
Journal:  Crit Care       Date:  2009-09-11       Impact factor: 9.097
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.